Q301 Cream

DRUG2 trials

Sponsors

Qurient Co., Ltd.

Conditions

Atopic DermatitisModerate to Severe Atopic Dermatitis

Phase 2

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

CompletedNCT02426359

Qurient Co., Ltd.Moderate to Severe Atopic Dermatitis

Start: 2015-04-30End: 2016-05-31Updated: 2016-12-06

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

CompletedNCT03571620

Qurient Co., Ltd.Atopic Dermatitis

Start: 2018-06-21End: 2020-04-21Updated: 2020-04-24